News Channels

22 Sep 2017 Roche receives European approval for Actemra /RoActemra in giant cell arteritis
22 Sep 2017 Roche receives EU approval of Gazyvaro for people with previously untreated advanced follicular lymphoma
22 Sep 2017 Versartis Announces Phase 3 VELOCITY Trial of Somavaratan in Pediatric Growth Hormone Deficiency Did Not Meet Primary Endpoint
22 Sep 2017 Dova Pharmaceuticals Announces New Drug Application Submission to FDA for Avatrombopag, a Second Generation Thrombopoietin Receptor Agonist
22 Sep 2017 Auris Medical Completes Patient Recruitment for Phase 3 TACTT3 Trial of Keyzilen® in Acute and Post-Acute Tinnitus
22 Sep 2017 AbbVie and Bristol-Myers Squibb Announce Clinical Research Collaboration to Evaluate a Therapeutic Regimen in Advanced Solid Tumors
22 Sep 2017 New Data from CENTAUR Phase 2b Clinical Study Supports Continued Development of Cenicriviroc (CVC) in Ongoing Phase 3 AURORA Trial
22 Sep 2017 Eisai presents latest non-clinical data on its first antibody-drug conjugate MORAb-202 at 8th Annual World ADC
21 Sep 2017 Provention Bio Announces Licensing Agreements with Janssen for Two Clinical-Stage Immunology Assets
21 Sep 2017 Audentes Therapeutics Announces Dosing of First Patient in ASPIRO, a Phase 1/2 Clinical Trial of AT132 for the Treatment of X-Linked Myotubular Myopathy
21 Sep 2017 Bavarian Nordic Provides Update on its Universal RSV Vaccine
21 Sep 2017 Krystal Biotech Announces Presentation of KB103 Data at EB2017 - The 5th World Conference of EB Research
21 Sep 2017 Cellectar Biosciences Enters into Strategic Collaboration with Onconova Therapeutics to Develop New Phospholipid Drug Conjugates
21 Sep 2017 FLX Bio Selects Immuno-Oncology Clinical Candidate
21 Sep 2017 AVROBIO, Inc. Expands Rare Disease Pipeline with Gene Therapy to Treat Pompe Disease
21 Sep 2017 BioCryst's RAPIVAB® (peramivir injection) Receives FDA Approval for a Pediatric Indication
21 Sep 2017 Inovio dMAb™ Constructs Shrink Prostate Tumors and Protect Against Lethal Antibiotic-Resistant Bacterial Infection In Preclinical Studies
21 Sep 2017 MorphoSys Announces That Its Licensee Janssen Has Initiated Two Phase 3 Studies with TremfyaTM (Guselkumab) in Psoriatic Arthritis
21 Sep 2017 European Commission Approves Bavencio (avelumab) for Metastatic Merkel Cell Carcinoma
21 Sep 2017 PharmaMar starts clinical studies with a new compound –PM14- in patients with solid tumors

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top